Drugs Therapeutic Equivalence Code

$179 / year

This dataset contains the Therapeutic Equivalence Code part to build the Drugs@FDA database. Application Documents refers to “document addresses or URLs to letters, labels, reviews, Consumer Information Sheets, FDA Talk Papers, and other types. Drugs at FDA is a database of FDA Approved Drug Products. It provides information of drug (generic) name, active ingredient, form and strength available, FDA application number, label info, dosage form or route, marketing status and other facts.


Drugs@FDA allows to search for official information about FDA approved innovator and generic drugs and therapeutic biological products. The main uses of Drugs@FDA are: finding labels for approved drug products, generic drug products for an innovator drug product, therapeutically equivalent drug products for an innovator or generic drug product, consumer information for drugs approved from 1998 on, all drugs with a specific active ingredient, viewing the approval history of a drug.

Drugs@FDA contains prescription and over-the-counter human drugs and therapeutic biologicals currently approved for sale in the United States. Drugs@FDA includes discontinued drugs and “Chemical Type 6″ approvals.

Drugs@FDA contains the following therapeutic biological products:
– monoclonal antibodies
– cytokines, growth factors, enzymes, immunomodulators; and thrombolytics
– proteins intended for therapeutic use that are extracted from animals or microorganisms, including recombinant versions of these products (except clotting factors)
– other non-vaccine therapeutic immunotherapies

Not all therapeutic biological products are in Drugs@FDA.
Drugs@FDA contains most of the drug products approved since 1939. The majority of labels, approval letters, reviews, and other information are available for drug products approved from 1998 to the present.

Drugs@FDA does not include:
– over-the-counter (OTC) products approved for marketing through a process other than submission of a New Drug Application or Biologic License Application
– drugs sold outside the United States that are not approved for marketing in the U.S.
– drugs not approved by the FDA
– drugs under review at FDA for which no action (approved or not approved) has occurred yet
– dietary supplements, which do not require FDA approval to be sold in the United States
– biological products regulated by the Center for Biologics Evaluation and Research
– animal drugs, which are regulated by the Center for Veterinary Medicine”

Source: US Food and Drug Administration, F.D.A. (2016). FDA.gov. Retrieved 8 May, 2016.

Date Created


Last Modified




Update Frequency


Temporal Coverage


Spatial Coverage



John Snow Labs; US Food and Drug Administration;

Source License URL

Source License Requirements


Source Citation



Drugs Database, SQL Database, SQL Drugs Database, Online Drug Database, FDA Approved Drug Products, Drugs FDA, FDA Official Drug Website, FDA Generic Drugs List, FDA Therapeutic Equivalence Codes, Therapeutic Equivalence Codes

Other Titles

Drugs@FDA, Drugs at FDA Product TE Code, Product Therapeutic Equivalence Code

Application_NumberApplication number of FDA approved drug productintegerlevel : Nominal
Product_NumberProduct number of FDA approved drug productintegerlevel : Nominal
Marketing_Status_IDMarketing status indicates how a drug product is sold in the United States. 1= Prescription, 2= Over-the-counter, 3= Discontinued, 4= None (Tentative Approval)integerlevel : Nominal
Therapeutic_Equivalence_CodeTherapeutic equivalence code of FDA approved drug productstring-
Application NumberProduct NumberMarketing Status IDTherapeutic Equivalence Code